drugset / Trial / NCT00656019
Development of Vitamin D as a Therapy for Breast Cancer - Phase 2
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will assess whether levels of vitamin D impact the characteristics of a woman's breast cancer at diagnosis, and whether a short course of vitamin D in women with low levels of vitamin D changes the gene expression of their breast cancers.
Timeline
- Start
- 2008-04
- Primary completion
- 2010-08
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vitamin D | Other / unclassified | 2000 iu | Oral |
| Subject | Vitamin D | Other / unclassified | 4000 iu | Oral |
| Subject | Vitamin D | Other / unclassified | 6000 iu | Oral |